The Company has licensed the rights of its exenatide delivery system, supported by the proprietary NanoPortal platform, to development partner, Okava Pharmaceuticals, which is studying OKV-119 for the treatment of pre-diabetes, diabetes and obesity in companion felines
Heres what we know from the available data thus far: No reported toxicity in preclinical injection studies No behavioral or pathological abnormalities observed No adverse safety signals in topical skin care studies Theoretical concerns about copper overload exist, but no study to date has demonstrated this outcome with GHK-Cu
The Dutch National Health Counsel and the Regional Disciplinary Medical Board of Eindhoven have stated clearly that vitamin B12 is non-toxic
Methionine An amino acid helps the liver work properly
You can look at the full roster of clinicians on Sesame, and choose you think is the best fit for you, Botta explains